C1R
Complement C1r subcomponent
As of the edition of 20 October 2026, C1R (complement C1r subcomponent, UniProt P00736) has 1 drug tested at it and 2 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P00736
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- In more than one place
- Solved structures
- 12
- Disease areas
- Infections; Lungs and airways; Pregnancy and women's health; Urinary and reproductive
- Registered trials of its drugs
- 18
Drugs at this target
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Nafamostat | Active | Phase 4 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Engaged | 2 |
| Total on the list | 2 |